August 14, 2025 · Form 4 insider transaction
Sensenig Bethany sold 5,369 shares of Supernus Pharmaceuticals, Inc. at $42.25 per share, a transaction worth $226.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted May 15, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.88 to $42.52. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.